Barinthus Biotherapeutics plc
Barinthus Biotherapeutics plc (BRNS) stock FAQs
Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.
What is Barinthus Biotherapeutics plc (BRNS) stock price today?
As of Dec 16, 2025, 9:00 PM UTC, Barinthus Biotherapeutics plc (BRNS) stock is trading at $0.7385. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date BRNS stock quotes for informed trading decisions.
What is Barinthus Biotherapeutics plc's market capitalization?
Barinthus Biotherapeutics plc (BRNS) has a market capitalization of approximately $30.2M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Barinthus Biotherapeutics plc's size relative to other companies in the USD market. The market cap figure updates automatically as the BRNS stock price changes.
What is the 52-week range for Barinthus Biotherapeutics plc stock?
Barinthus Biotherapeutics plc (BRNS) stock has traded in a 52-week range of $0.64 — $2.92. The 52-week range shows the highest and lowest prices at which BRNS traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Barinthus Biotherapeutics plc stock price to this range provides context for recent price action.
How much trading volume does Barinthus Biotherapeutics plc stock have?
Barinthus Biotherapeutics plc (BRNS) stock recently traded approximately 40.1K shares. Trading volume indicates market liquidity and investor interest in BRNS. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Barinthus Biotherapeutics plc stock.
Does Barinthus Biotherapeutics plc pay dividends to shareholders?
Yes, Barinthus Biotherapeutics plc (BRNS) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Barinthus Biotherapeutics plc stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.
What is Barinthus Biotherapeutics plc's intraday price range?
Today, Barinthus Biotherapeutics plc (BRNS) stock has traded in a range of $0.7076 — $0.74. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring BRNS's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.
Where does AlphaPilot get Barinthus Biotherapeutics plc stock data?
AlphaPilot sources real-time BRNS stock quotes, fundamental financial data, and historical price charts for Barinthus Biotherapeutics plc from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Barinthus Biotherapeutics plc stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of BRNS stock performance.